Skip to main content
. 2009 Mar;2(2):115–128. doi: 10.1177/1756285608101861

Table 3.

Therapeutic options in PML [Stüve et al. 2007].

Therapeutic options in natalizumab-associated PML
Antiviral therapy ▪Cidofovir
Topotecan
Mefloquine
Cytosine arabinoside
Immunomodulatories Interferon-beta
Interferon-alpha
Interleukin 2
5HT-2a receptor blockers
Intravenous immunoglobulins
Haematopoietic growth factors Granulocyte colony stimulating factors
Other interventions Plasmapheresis
Leukapheresis